Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Arch Med Sci ; 16(6): 1376-1386, 2020.
Article in English | MEDLINE | ID: mdl-33224337

ABSTRACT

INTRODUCTION: The aim of the study was to investigate whether melatonin has a protective effect against diminished ovarian reserve induced by smoking. MATERIAL AND METHODS: Seventy-two female Wistar-Albino rats were divided into 6 groups: group I (room air), group II (chronic cigarette smoking), group III (room air + 10 mg/kg subcutaneous melatonin), group IV (room air + 20 mg/kg subcutaneous melatonin), group V (chronic cigarette smoking + 10 mg/kg subcutaneous melatonin), group VI (chronic cigarette smoking + 20 mg/kg subcutaneous melatonin). For 45 days, rats were exposed to cigarette smoke through a smoking machine, then subcutaneous melatonin was administered. Apoptotic index, immunohistochemical scoring, ovarian follicle counting, ovarian tissue and serum malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT) analyses were carried out. RESULTS: All of the primordial, primary, secondary and mature follicle numbers were found to be significantly lowered in study groups. Increased HSCORE with anti-caspase-3 staining and a high follicular apoptotic index were demonstrated in the smoking group. Serum and ovarian tissue levels of MDA were found to be elevated with smoke exposure whereas lower MDA levels were determined in melatonin treated groups. Serum and tissue levels of SOD, GPx and CAT were shown to be reduced in the smoking group in comparison with melatonin treated and control groups. 20 mg/kg melatonin administration in the smoking group revealed significantly decreased HSCOREs and apoptotic indices. CONCLUSIONS: Cigarette smoking has been definitely shown to be associated with impaired ovarian reserve with respect to significantly diminished numbers of primordial, primary, secondary and mature follicles. Dose-related treatment of melatonin in smokers may provide an evidently reduced apoptotic index and improved antioxidant activity in tissue.

2.
World J Gastroenterol ; 21(23): 7134-41, 2015 Jun 21.
Article in English | MEDLINE | ID: mdl-26109799

ABSTRACT

Intrahepatic cholestasis of pregnancy (ICP) is a reversible pregnancy-specific cholestatic condition characterized by pruritus, elevated liver enzymes, and increased serum bile acids. It commences usually in the late second or third trimester, and quickly resolves after delivery. The incidence is higher in South American and Scandinavian countries (9.2%-15.6% and 1.5%, respectively) than in Europe (0.1%-0.2%). The etiology is multifactorial where genetic, endocrine, and environmental factors interact. Maternal outcome is usually benign, whereas fetal complications such as preterm labor, meconium staining, fetal distress, and sudden intrauterine fetal demise not infrequently lead to considerable perinatal morbidity and mortality. Ursodeoxycholic acid is shown to be the most efficient therapeutic agent with proven safety and efficacy. Management of ICP consists of careful monitoring of maternal hepatic function tests and serum bile acid levels in addition to the assessment of fetal well-being and timely delivery after completion of fetal pulmonary maturity. This review focuses on the current concepts about ICP based on recent literature data and presents an update regarding the diagnosis and management of this challenging issue.


Subject(s)
Cholestasis, Intrahepatic , Pregnancy Complications , Cholagogues and Choleretics/therapeutic use , Cholestasis, Intrahepatic/diagnosis , Cholestasis, Intrahepatic/epidemiology , Cholestasis, Intrahepatic/genetics , Cholestasis, Intrahepatic/therapy , Female , Genetic Markers , Genetic Predisposition to Disease , Humans , Incidence , Phenotype , Predictive Value of Tests , Pregnancy , Pregnancy Complications/diagnosis , Pregnancy Complications/epidemiology , Pregnancy Complications/genetics , Pregnancy Complications/therapy , Risk Factors , Treatment Outcome , Ursodeoxycholic Acid/therapeutic use
3.
J Obstet Gynaecol Res ; 40(7): 1853-61, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25056462

ABSTRACT

AIM: The aim of study is to compare maternal and fetal outcomes of pregnancies in which cerclage was placed following the loss of first fetus with those without cerclage placement in multiple pregnancies for delayed interval delivery. METHODS: Records of pregnancies in which the first fetus was lost between 13-26 weeks and delayed delivery experienced for retained fetus(es), were collected retrospectively. A total of 20 patients including 11 twins, seven triplets and two quadruplets were evaluated. Cases with cervical cerclage placed after the first delivery were evaluated as the cerclage group (n = 11) and the cases without cerclage placement were evaluated as the non-cerclage group (n = 9). RESULTS: Median duration of delay was 22 days (range, 3-121) for both groups; 40 days (range, 5-121) in cerclage group and 12 days (range, 3-46) in the non-cerclage group (P = 0.003). Average birthweight of retained fetus(es) in the cerclage group was 850 ± 153.6 g (mean ± standard error [SE]) and 549.5 ± 149.1 g (mean ± SE) in the non-cerclage group (P = 0.04). Delivery week of retained fetus(es), live birth rate, take-home baby rate and chorioamnionitis ratio were not different in between the groups. CONCLUSION: Cervical cerclage after the first delivery is associated with a longer delivery interval and higher birthweight of retained fetus.


Subject(s)
Abortion, Spontaneous/prevention & control , Abortion, Threatened/surgery , Cerclage, Cervical/adverse effects , Pregnancy, High-Risk , Pregnancy, Multiple , Abortion, Incomplete/therapy , Abortion, Threatened/prevention & control , Adult , Female , Fetal Weight , Humans , Pregnancy , Pregnancy Outcome , Retrospective Studies , Turkey , Young Adult
4.
J Reprod Med ; 58(5-6): 212-8, 2013.
Article in English | MEDLINE | ID: mdl-23763005

ABSTRACT

OBJECTIVE: To describe menstrual abnormalities and intrauterine adhesions within 5 years after a transuterine compression suture and uterine devascularization with hypogastric ligation. STUDY DESIGN: Prospective clinical follow-up was conducted on 56 patients who underwent uterine devascularization with hypogastric ligation and transuterine suture. The main outcomes were to investigate intrauterine adhesions, menstrual pattern, and desire for subsequent pregnancy and fertility. RESULTS: Among 56 cases, abnormal placental implantation was diagnosed in 30 (53.6%) (Group 1), and uterine atony was diagnosed in 26 (46.4%) (Group 2). Before pregnancy, while 2/24 patients in Group 1 and 2/23 patients in Group 2 had menstrual irregularities, after pregnancy 8/24 patients in Group 1 and 9/23 patients in Group 2 had menstrual irregularities (p = 0.03 and 0.01, respectively). Hysteroscopic examination revealed normal findings in 16 patients in Group 1 (66.6%) and 20 patients in Group 2 (86.9%) (p > or = 0.05). Among patients who had desired a future pregnancy, 2 of 4 patients (50%) in Group 1 and 4 of 5 patients (80%) in Group 2 subsequently had achieved successful pregnancies. CONCLUSION: Transuterine compression suture and uterine devascularization with hypogastric ligation in managing postpartum hemorrhage appear to have achieved preserved fertility and, in most cases, menstrual regularity.


Subject(s)
Menstruation Disturbances/epidemiology , Postpartum Hemorrhage/surgery , Suture Techniques , Adult , Female , Fertility , Hemostasis, Surgical , Humans , Ligation , Pregnancy , Suture Techniques/adverse effects , Tissue Adhesions/epidemiology , Uterine Diseases/epidemiology , Uterus/blood supply
5.
Arch Gynecol Obstet ; 283(5): 941-5, 2011 May.
Article in English | MEDLINE | ID: mdl-20422420

ABSTRACT

PURPOSE: To evaluate the maternal and fetal outcome in 44 pregnancies complicated with HELLP syndrome and to investigate the role of platelet counts in its prognosis. METHODS: A retrospective analysis of the medical records of 44 patients with the diagnosis of hemolysis elevated liver enzymes and low platelet count between June 1997 and January 2009 was performed. The patients were divided into two groups according to blood platelet count: platelet count <50,000 mm(3) formed Group I and platelet count 50,000-100,000 mm(3) formed Group II. Clinical findings and laboratory characteristics, maternal complications, perinatal outcomes and comparison of maternal and fetal morbidity according to platelet counts were analyzed. RESULTS: During the period of 12 years, 44 (0.54%) of 8,132 deliveries had HELLP syndrome. Among 44 patients, the most common complications were disseminated intravascular coagulopathy (18.2%), acute renal failure (15.9%), abruptio placentae (11.4%), and cerebral hemorrhage/infarction (11.4%). Maternal and perinatal mortality rates in HELLP syndrome were 9.1 and 40.9%, respectively. Aspartate aminotransferase levels were found to be statistically significantly higher in Group I (p = 0.04). While disseminated intravascular coagulopathy and acute renal failure were statistically significantly higher in Group I (p = 0.01; p = 0.03 respectively), fetal growth restriction was statistically significantly higher in Group II (p = 0.04). CONCLUSIONS: HELLP syndrome is associated with high incidences of maternal and fetal morbidity and mortality and patients with low platelet counts might have a much increased risk.


Subject(s)
HELLP Syndrome/blood , Adult , Female , Fetal Death/epidemiology , HELLP Syndrome/diagnosis , HELLP Syndrome/mortality , Humans , Platelet Count , Pregnancy , Pregnancy Outcome , Prognosis , Retrospective Studies , Turkey/epidemiology
6.
Fertil Steril ; 94(4): 1314-1319, 2010 Sep.
Article in English | MEDLINE | ID: mdl-19589516

ABSTRACT

OBJECTIVE: To determine whether 25OH-D levels in the follicular fluid (FF) of infertile women undergoing IVF demonstrate a relationship with IVF cycle parameters and outcome, hypothesizing that levels of 25OH-D in body fluids are reflective of vitamin repletion status. DESIGN: Prospective cohort study. SETTING: Academic tertiary care center. PATIENT(S): Eighty-four infertile women undergoing IVF. INTERVENTION(S): Follicular fluid from follicles>or=14 mm; serum (n = 10) and FF levels of 25OH-D. MAIN OUTCOME MEASURE(S): Clinical pregnancy (CP), defined as evidence of intrauterine gestation sac on ultrasound, following IVF; IVF cycle parameters. RESULT(S): Serum and FF levels of 25OH-D were highly correlated (r=0.94). In a predominantly Caucasian population (66%), significantly lower FF 25OH-D levels were noted in Black versus non-Black patients. Significant inverse correlations were seen between FF 25OH-D levels and body mass index (r=-0.25). Significantly higher CP and implantation rates were observed across tertiles of FF25OH-D; patients achieving CP following IVF (n=26) exhibited significantly higher FF levels of 25OH-D. Multivariable logistic regression analysis confirmed FF 25OH-D levels as an independent predictor to success of an IVF cycle; adjusting for age, body mass index, ethnicity, and number of embryos transferred, each ng/mL increase in FF 25OH-D increased the likelihood for achieving CP by 6%. CONCLUSION(S): Our findings that women with higher vitamin D level in their serum and FF are significantly more likely to achieve CP following IVF-embryo transfer are novel. A potential for benefit of vitamin D supplementation on treatment success in infertile patients undergoing IVF is suggested and merits further investigation.


Subject(s)
Fertilization in Vitro , Follicular Fluid/chemistry , Infertility, Female/diagnosis , Infertility, Female/therapy , Vitamin D/analysis , Adult , Cohort Studies , Embryo Implantation/physiology , Female , Follicular Fluid/metabolism , Humans , Infertility, Female/blood , Infertility, Female/metabolism , Predictive Value of Tests , Pregnancy , Pregnancy Rate , Reproduction/physiology , Treatment Outcome , Vitamin D/blood , Vitamin D/metabolism
7.
Arch Gynecol Obstet ; 280(1): 19-24, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19034471

ABSTRACT

OBJECTIVE: To compare efficacy and safety of vaginal misoprostol (PGE(1) analog) with dinoprostone (PGE(2) analog) vaginal insert for labor induction in term pregnancies. STUDY DESIGN: A total of 112 women with singleton pregnancies of > or =37 weeks of gestation, and low Bishop scores underwent labor induction. The subjects were randomized to receive either 50 mug misoprostol intravaginally every 4 h to a maximum of five doses or a 10 mg dinoprostone vaginal insert for a maximum of 12 h. Time interval from induction to vaginal delivery, vaginal delivery rates within 12 and 24 h, requirement of oxytocin augmentation, incidence of tachysystole and uterine hyperstimulation, mode of delivery, rate of cesarean section due to fetal distress and neonatal outcome were outcome measures. Student's t test, Chi square test, Fischer's exact test were used for statistical analysis. RESULTS: Time interval from induction to vaginal delivery was found to be significantly shorter in misoprostol group when compared to dinoprostone subjects (680 +/- 329 min vs. 1070 +/- 435 min, P < 0.001). Vaginal delivery rates within 12 h were found to be significantly higher with misoprostol induction [n = 37 (66%) vs. n = 25 (44.6%); P = 0.02], whereas vaginal delivery rates in 24 h did not differ significantly between groups [n = 41 (73.2%) vs. n = 36 (64.2%); P = 0.3]. More subjects required oxytocin augmentation in dinoprostone group [n = 35 (62.5%) vs. n = 20 (35.7%), P = 0.005] and cardiotocography tracings revealed early decelerations occurring more frequently with misoprostol induction (10.7 vs. 0%, P = 0.03). Tachysystole and uterine hyperstimulation, mode of delivery, rate of cesarean sections due to fetal distress and adverse neonatal outcome were not demonstrated to be significantly different between groups (P = 1, P = 0.5, P = 0.4, P = 0.22, P = 0.5). CONCLUSION: Using vaginal misoprostol is an effective way of labor induction in term pregnant women with unfavorable cervices, since it is associated with a shorter duration of labor induction and higher rates of vaginal delivery within 12 h. Misoprostol and dinoprostone are equally safe, since misoprostol did not result in a rise in maternal and neonatal morbidity, namely, tachysystole, uterine hyperstimulation, cesarean section rates and admission to neonatal intensive care units as reported previously in literature.


Subject(s)
Labor, Induced/methods , Misoprostol/administration & dosage , Oxytocics/administration & dosage , Administration, Intravaginal , Cardiotocography , Chi-Square Distribution , Dinoprostone/administration & dosage , Dinoprostone/adverse effects , Dinoprostone/pharmacology , Female , Heart Rate, Fetal/drug effects , Humans , Misoprostol/adverse effects , Misoprostol/pharmacology , Oxytocics/adverse effects , Oxytocics/pharmacology , Pregnancy , Pregnancy Complications , Pregnancy Outcome , Pregnancy Trimester, Third , Time Factors
8.
Arch Gynecol Obstet ; 279(6): 897-9, 2009 Jun.
Article in English | MEDLINE | ID: mdl-18836735

ABSTRACT

Albeit very uncommon, the hernia sac may contain unusual structures such as vermiform appendix, acute appendicitis, ovary, fallopian tube and, urinary bladder. Most of the cases of hernia containing ovary and fallopian tubes were reported to be found in children and, often accompanied with other congenital anomalies of genital tract. We present the first case of sliding inguinal hernia containing right ovary and fallopian tube and a right paraovarian cyst in 80-year-old, multiparous patient without any associated genital anomaly. The hernia was repaired with plication darn, while the paraovarian cyst was excised and adnexa were preserved. It is of utmost importance to keep in mind that the hernia sac may contain almost any abdominal organ, and surgical dissection should be carried out accordingly. Pathophysiologically, the ovary might be simply pulled along with a sliding paraovarian cyst or the paraovarian cyst might be accompanying the maldescended ovary. There seems to be a need for clinical and experimental studies to further explain the mechanisms that apply to the pathogenesis of sliding inguinal hernias.


Subject(s)
Fallopian Tubes/pathology , Hernia, Inguinal/pathology , Ovarian Cysts/pathology , Ovary/pathology , Aged, 80 and over , Female , Humans
9.
Gynecol Obstet Invest ; 67(2): 81-91, 2009.
Article in English | MEDLINE | ID: mdl-18931504

ABSTRACT

Endometriosis, defined as the presence of endometrial tissue outside the uterus, is a challenging condition associated with substantial morbidity. Management of endometriosis must be individualized according to the desired treatment outcome, whether it is relief of pain, improvement of fertility, or the prevention of recurrence. For alleviation of endometriosis-associated pain, medical treatment is generally successful, with no medical agent being more efficacious than another in spite of significantly differing side-effect profiles. Surgical therapy has also been demonstrated to reduce pain scores in comparison with expectant management, although conservative surgery has been frequently associated with recurrence. The efficacy of combination therapies still remains to be clarified. For treatment of endometriosis-associated infertility, suppressive medical treatment has been proven to be detrimental to fertility and should be discouraged, while surgery is probably efficacious for all stages. Controlled ovarian hyperstimulation with intrauterine insemination is recommended in early-stage and surgically corrected endometriosis. Combined surgery with GnRH analog treatment has been proposed to be first-line therapy, followed by IVF as second-line therapy in advanced cases. More rigorously designed randomized clinical trials focusing on the endocrinological, immunological, and genetic aspects of endometriosis are necessary to refine conclusions regarding the etiopathogenesis and therapeutic innovations of this perplexing disease.


Subject(s)
Endometriosis/therapy , Infertility, Female/prevention & control , Pelvic Pain/physiopathology , Adult , Combined Modality Therapy , Drug Therapy, Combination , Endometriosis/complications , Endometriosis/diagnosis , Evidence-Based Medicine , Female , Forecasting , Gynecologic Surgical Procedures/methods , Gynecologic Surgical Procedures/trends , Hormone Antagonists/therapeutic use , Hormones/therapeutic use , Humans , Infertility, Female/etiology , Middle Aged , Pain Measurement , Pelvic Pain/etiology , Pelvic Pain/therapy , Prognosis , Randomized Controlled Trials as Topic , Risk Assessment , Severity of Illness Index , Treatment Outcome , Young Adult
10.
J Turk Ger Gynecol Assoc ; 10(3): 162-7, 2009.
Article in English | MEDLINE | ID: mdl-24591861

ABSTRACT

OBJECTIVE: To investigate the mothers' anxiety levels and determine its effect on fetomaternal circulation in pregnant women undergoing genetic amniocentesis. MATERIAL AND METHODS: A prospective case-control study was conducted regarding the assessment of maternal anxiety levels by means of the Spielberger State-Trait Anxiety Inventory in 60 pregnant women having genetic amniocentesis and 60 control cases having their early second trimester ultrasonographic screening, 30 minutes before and immediately after the procedure. Additionally, maternal-fetal hemodynamic changes and Doppler ultrasonographic measurements of fetoplacental circulation were recorded in both groups. RESULTS: The maternal anxiety state scores were found to be significantly higher in the amniocentesis group (p<0.001). Maternal heart rate was significantly higher in the amniocentesis group (p<0.05), while the fetal heart rate was significantly lower (p<0.05) compared to the control group. Uterine artery Doppler measurements were comparable in the two groups but umbilical artery resistance index (p<0.05) and S/D ratio (p<0.05) were significantly higher in the amniocentesis group. Regression analysis revealed that the time which elapsed from offering amniocentesis until it was performed is the main predictor of fetal umbilical artery S/D ratio measured prior to amniocentesis in the amniocentesis group (ß=0.66, p<0.001) and maternal anxiety state scores (ß=0.04, p=0.003) are the main predictors of fetal umbilical artery S/D ratio measured prior to amniocentesis or ultrasonography in the two groups. The education of the patient in years decreased (ß=-0.13, p=0.04), while the amniocentesis procedure (ß=1.44, p=0.02) and the time which elapsed in days from offering amniocentesis or ultrasonography up to its performance (ß=0.41, p=0.04) increased the S/D ratio measured after the procedures. CONCLUSION: Our study provides the evidence that maternal anxiety and its duration has effects on the fetal blood flow. Early booking and patient support may help to overcome undesired consequences of an invasive prenatal procedure.

11.
J Matern Fetal Neonatal Med ; 21(11): 831-8, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18979395

ABSTRACT

OBJECTIVE: To investigate placental expression of insulin-like growth factor-I (IGF-I), fibroblast growth factor-basic (FGF-b), and neural cell adhesion molecule (N-CAM) in preeclampsia. STUDY DESIGN: An immunohistochemical analysis using IGF-I, FGF-b, and N-CAM antibodies was conducted on 4% paraformaldehyde-fixed placental tissues of preeclamptic patients (N = 14) and normotensive pregnant subjects (N = 10). Immunostaining patterns of chorionic villi and amniochorionic membranes were assessed. RESULTS: Significantly increased FGF-b and N-CAM immunoreactivities in cytotrophoblasts and increased FGF-b immunoreactivity in capillary endothelium of chorionic villi of preeclamptic subjects were noted. Significantly increased FGF-b and decreased N-CAM immunoreactivities in extravillous trophoblasts and decidual cells of amniochorionic membranes obtained from preeclamptic subjects were demonstrated. Additionally, a significantly increased IGF-I immunoreactivity was shown in decidual cells of preeclamptic cases. CONCLUSION: Investigation of the regional distribution of IGF-I, FGF-b, and N-CAM at the maternal-fetal interface establishes a better understanding of cell-specific altered growth processes, which may be associated with the pathogenesis of preeclampsia.


Subject(s)
Fibroblast Growth Factor 2/metabolism , Insulin-Like Growth Factor I/metabolism , Neural Cell Adhesion Molecules/metabolism , Placenta/metabolism , Pre-Eclampsia/metabolism , Adult , Case-Control Studies , Female , Humans , Immunohistochemistry , Pre-Eclampsia/etiology , Pregnancy , Young Adult
12.
J Obstet Gynaecol Res ; 34(5): 824-31, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18834341

ABSTRACT

AIM: To determine how fetal pulse oximetry behaves in various cardiotocographic (CTG) tracings and correlates with neonatal outcome. PATIENTS AND METHODS: Pregnant women undergoing active labor with singleton pregnancies of 32-42 weeks were enrolled. CTG recordings were reassuring or nonreassuring (namely variable or persisting late decelerations). Pulse oximetry values during labor and changing throughout deceleration and recovery phases, duration and frequency of pulse oximetry recordings <30%, and neonatal outcome were determined. One-way anova, Tukey test, chi(2)-test and multiple logistic regression model were used for statistical analysis where appropriate. RESULTS: A total of 156 pregnant subjects were divided into three groups: reassuring fetal heart rate (FHR) patterns (group 1, n=78 [50%]), late decelerations (group 2, n=16 [10.3%]) and variable decelerations (group 3, n=62 [39.7%]). The initial and final pulse oximetry readings, pulse values in first stage of labor, the duration and the frequency of pulse oximetry recordings <30% were significantly different between groups (P<0.001, P<0.001, P<0.001, P=0.001, P<0.001). Fetal acidosis was significantly more frequent with late decelerations (23.1%, P=0.004). A multiple logistic regression model demonstrated that the initial pulse oximetry value during active labor was the most predictive variable of neonatal well-being (P<0.001). CONCLUSION: Decreased fetal pulse oximetry values, especially prolonged and recurrent recordings <30% are well-correlated with abnormal FHR patterns, indicating an association with fetal compromise and metabolic acidosis. Going through active labor with a lower initial value of FSpO(2) more frequently leads to an altered FHR pattern and subsequent adverse fetal outcome.


Subject(s)
Fetal Monitoring/methods , Heart Rate, Fetal/physiology , Oximetry/methods , Adult , Birth Weight , Cardiotocography , Female , Fetus , Humans , Infant, Newborn , Pregnancy , Young Adult
13.
Ann N Y Acad Sci ; 1127: 92-100, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18443335

ABSTRACT

Endometriosis is an estrogen-dependent disorder defined as the presence of endometrial tissue outside of the uterine cavity. A leading cause of infertility, endometriosis has a prevalence of 0.5-5% in fertile and 25-40% in infertile women. The optimal choice of management for endometriosis-associated infertility remains obscure. Removal or suppression of endometrial deposits by medical or surgical means constitutes the basis of endometriosis management. Current evidence indicates that suppressive medical treatment of endometriosis does not benefit fertility and should not be used for this indication alone. Surgery is probably efficacious for all stages of the disease. Controlled ovarian hyperstimulation with intrauterine insemination is recommended in early-stage and surgically corrected endometriosis when pelvic anatomy is normal. In advanced cases, in vitro fertilization is a treatment of choice, and its success may be augmented with prolonged gonadotropin-releasing hormone analog treatment. Further randomized clinical trials focusing on diverse etiopathogenic mechanisms and therapeutic innovation are necessary to find more conclusive, evidence-based answers regarding this enigmatic disease.


Subject(s)
Endometriosis/epidemiology , Endometriosis/therapy , Infertility, Female/epidemiology , Infertility, Female/therapy , Endometriosis/complications , Evidence-Based Medicine , Female , Fertilization in Vitro , Humans , Infertility , Infertility, Female/complications , Male , Ovulation Induction , Pregnancy , Prevalence , Reproductive Techniques, Assisted , Treatment Outcome
14.
J Pediatr Surg ; 43(4): 765-7, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18405732

ABSTRACT

Distal vaginal agenesis is one of the rarest congenital malformations of female genital tract. We describe successfully operated teenaged monozygotic twins by combined abdominal and perineal approach. The imaging studies and surgical experience were presented.


Subject(s)
Diseases in Twins/diagnosis , Diseases in Twins/surgery , Vagina/abnormalities , Vagina/surgery , Abdominal Pain/etiology , Adolescent , Anastomosis, Surgical , Female , Humans
15.
J Obstet Gynaecol Res ; 33(6): 873-7, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18001457

ABSTRACT

Implantation of conception material within a cesarean section scar is an extremely rare form of ectopic pregnancy with devastating complications, such as uterine rupture and intractable bleeding. Both 2-D and 3-D transvaginal ultrasonographic devices are used adequately for precise diagnosis, but there is still a lack of consensus concerning management strategies. No therapeutic modality is suggested to be entirely efficacious and safe for preserving uterine integrity. We present here a 29-year-old woman with vaginal bleeding and a gestational sac with a viable embryo of 6 weeks of age that was implanted in a cesarean section scar. Serum beta-hCG levels were 16 792 mIU/mL. Following an unsuccessful treatment course of systemic methotrexate, the patient underwent operative hysteroscopy. Minimally invasive hysteroscopic resection of the ectopic gestational mass without major complication appears to be an alternative therapeutic approach with minimal morbidity and preservation of future fertility.


Subject(s)
Cesarean Section/adverse effects , Cicatrix/diagnostic imaging , Cicatrix/surgery , Pregnancy, Ectopic/diagnostic imaging , Pregnancy, Ectopic/surgery , Adult , Cicatrix/etiology , Female , Humans , Hysteroscopy , Imaging, Three-Dimensional , Pregnancy , Pregnancy, Ectopic/etiology , Treatment Outcome , Ultrasonography
16.
J Reprod Med ; 52(6): 563-6, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17694986

ABSTRACT

BACKGROUND: Uterine artery embolization (UAE) is promising, minimally invasive therapy being offered to women for treatment of fibroids. Although it seems to be safe and effective, major complications and adverse outcomes have been reported. CASE: A patient treated with UAE for a huge cervical fibroid presented with an infected, necrotic cervical mass lesion 4 weeks after the procedure. Spontaneous vaginal expulsion of the infected cervical fibroid from the left lateral cervical fistula tract occurred 3 weeks later while the patient was receiving antibiotic therapy. After 6 months of intervention, an approximately 99% regression rate in the fibroid volume was achieved. The patient gave birth to a healthy, female infant following a spontaneous, uneventful pregnancy and vaginal delivery. CONCLUSION: UAE appears to be associated with a significant reduction in fibroid volume. Expulsion of the infected, necrotic parts of the fibroid after UAE may be accepted as a natural process. Warning the patient about this potential risk, early recognition of infective complications and lose follow up seem to be crucial to avoiding potentially fatal septic shock.


Subject(s)
Embolization, Therapeutic/adverse effects , Fistula/etiology , Leiomyoma/therapy , Uterine Cervical Diseases/etiology , Uterine Neoplasms/therapy , Adult , Anti-Bacterial Agents/therapeutic use , Cervix Uteri/pathology , Female , Humans , Leiomyoma/complications , Necrosis/drug therapy , Uterine Neoplasms/complications , Uterus/blood supply , Vaginal Discharge
17.
J Clin Ultrasound ; 35(7): 382-6, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17551944

ABSTRACT

PURPOSE: To determine whether spectral Doppler measurements obtained from bilateral uterine, arcuate, radial, and spiral arteries in early gestation correlate with adverse pregnancy outcome. METHODS: One hundred five pregnant women underwent transvaginal Doppler sonographic examination of uteroplacental circulation at 6-12 weeks' gestation. Resistance index (RI) and pulsatility index (PI) of bilateral uterine, arcuate, radial, and spiral arteries were measured. Diameters of gestational sac (GS) and yolk sac, crown-rump length (CRL), GS-CRL difference, and GS/CRL ratio were also recorded. Correlation was made with pregnancy outcome. RESULTS: Sixteen women developed adverse pregnancy outcome. In these women, right uterine artery PI and RI were significantly higher than in women with normal obstetrical outcome. Spiral artery PI and RI values were also higher, but the difference was not statistically significant. GS-CRL difference, GS/CRL ratio, and yolk sac diameters were significantly lower in this group. CONCLUSION: Transvaginal Doppler examination can detect hemodynamic changes in uteroplacental circulation associated with subsequent adverse pregnancy outcome.


Subject(s)
Placental Circulation , Pregnancy Complications/diagnosis , Pregnancy Outcome , Pregnancy Trimester, First , Ultrasonography, Doppler/methods , Ultrasonography, Interventional/methods , Adult , Female , Humans , Placenta/blood supply , Placenta/diagnostic imaging , Predictive Value of Tests , Pregnancy , Uterus/blood supply , Uterus/diagnostic imaging
18.
J Clin Ultrasound ; 35(6): 305-13, 2007.
Article in English | MEDLINE | ID: mdl-17471581

ABSTRACT

PURPOSE: To study the blood flow patterns of utero-ovarian circulation in polycystic ovary syndrome (PCOS) and to assess their relationship with clinical, metabolic, and hormonal data. METHODS: Forty-three women with PCOS and 43 age-matched healthy controls underwent Doppler examination of the utero-ovarian circulation in the follicular phase. Demographic, hormonal, and metabolic parameters were determined. Student's t-test, chi(2)-test, and Spearman correlation test were used for statistical analysis. RESULTS: The ovarian artery pulsatility index (PI), resistance index (RI), and SD ratios were significantly lower in PCOS than in controls on the right side (p < 0.001, p = 0.02, p = 0.001, respectively) as well as on the left side (p < 0.001, p < 0.001, p < 0.001, respectively). The uterine artery systolic/diastolic (S/D) ratio was higher on both sides (p = 0.01) and the PI was higher on the left side (p = 0.02) in PCOS than in controls. The right uterine artery PI was positively correlated with luteinizing hormone and hemoglobin (r = 0.417, p = 0.043; r = 0.427, p = 0.033, respectively), the right uterine artery S/D was positively correlated with body mass index (r = 0.479, p = 0.015), and the left uterine artery PI was positively correlated with insulin (r = 0.458, p = 0.021). CONCLUSION: Doppler sonography of the utero-ovarian circulation may contribute to the evaluation of PCOS patients and a better understanding of the pathophysiology of this syndrome.


Subject(s)
Ovary/blood supply , Polycystic Ovary Syndrome/diagnostic imaging , Ultrasonography, Doppler, Color , Uterus/blood supply , Adult , Arteries/diagnostic imaging , Blood Pressure/physiology , Body Mass Index , Case-Control Studies , Female , Follicular Phase/physiology , Hemoglobins/analysis , Humans , Insulin/blood , Luteinizing Hormone/blood , Ovary/diagnostic imaging , Polycystic Ovary Syndrome/physiopathology , Prospective Studies , Pulsatile Flow/physiology , Regional Blood Flow/physiology , Sex Hormone-Binding Globulin/analysis , Ultrasonography, Doppler, Duplex , Uterus/diagnostic imaging , Vascular Resistance/physiology
19.
J Obstet Gynaecol Res ; 33(2): 166-73, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17441890

ABSTRACT

AIM: To determine whether serum prostate-specific antigen (PSA) levels are increased in polycystic ovary syndrome (PCOS) and the possibility of PSA to be used as a diagnostic marker of hyperandrogenism in females. METHODS: A total of 43 women with PCOS and 43 age-matched healthy females were recruited in this prospective case-control study. The subjects were compared by means of demographic parameters, hormonal and metabolic measures and serum PSA levels. The correlations between this marker and a wide variety of hormonal, biochemical, anthropometric measures were evaluated. Student's t-test, chi2-test and Spearman's correlation analysis were used for the statistical analysis where appropriate. Statistical significance was assumed with a value of P<0.05. RESULTS: Mean body mass index, waist/hip ratio, Ferriman-Gallwey scores (FG), lutenizing hormone/follicle stimulating hormone ratio, insulin resistance, serum triglycerides and very low density lipoprotein levels were demonstrated to be significantly higher in PCOS (P=0.02, P=0.008, P

Subject(s)
Biomarkers/blood , Hyperandrogenism/diagnosis , Polycystic Ovary Syndrome/blood , Polycystic Ovary Syndrome/diagnosis , Prostate-Specific Antigen/blood , Adult , Case-Control Studies , Female , Humans , Prospective Studies
20.
Arch Gynecol Obstet ; 274(1): 47-9, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16283407

ABSTRACT

Gastric carcinoma associated with pregnancy appears to be an extremely rare entity. It is usually diagnosed at advanced stages of the disease and presents a grave prognosis. Since the fatal outcome shows a rapid course within months of diagnosis, prompt gastroduodenal endoscopic examination following early clinical suspicion is mandatory. A case of 29 year-old pregnant woman with 31 weeks of gestation is herein presented. The women was diagnosed as gastric adenocarcinoma while being investigated for intractable nausea, vomiting, and a concomitant epigastric mass. She underwent radical gastric resection and received six cycles of adjuvant chemotherapy following vaginal delivery of a healthy 1950 g fetus. The patient was dead 20 weeks after the surgery due to pulmonary and hepatic metastasis.


Subject(s)
Adenocarcinoma/surgery , Pregnancy Complications, Neoplastic/surgery , Stomach Neoplasms/surgery , Adenocarcinoma/complications , Adenocarcinoma/drug therapy , Adult , Fatal Outcome , Female , Humans , Infant, Newborn , Labor, Induced , Live Birth , Male , Nausea/etiology , Pregnancy , Pregnancy Complications, Neoplastic/drug therapy , Pregnancy Trimester, Third , Stomach Neoplasms/complications , Stomach Neoplasms/drug therapy , Vomiting/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...